Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | GUTS Fractyl Health, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.49 +3.3% | $14.86 -2.5% |
| StockIQ Score | 36F Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 13F | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 26F | 50C- |
| Fair Value | 50C- | 38F |
| News | 62C+ | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
GUTS outperforms AAPG in fundamental (46 vs. 35) and valuation (50 vs. 38) scores, showing stronger stability and pricing relative to its assets. However, AAPG leads in growth (50 vs. 26), indicating faster expected expansion. Both share a "WEAK" rating, but GUTS has higher technical stability (24 vs. 18). Investor confidence is slightly higher for GUTS (39 vs. 37).
